Syracuse, NY, United States of America

Xiaotian Ji

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The State University of New York. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaotian Ji. Retrieved from https://idiyas.com/inventor/xiaotian-ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaotian Ji: Inventor in Nanocarrier Drug Delivery.

Introduction

Xiaotian Ji is an inventor associated with Syracuse, New York, and The State University of New York. His patent work addresses the delivery of amphotericin B, a drug used to treat serious fungal infections.

Latest Patents

Ji is named on 1 patent: “Telodendrimer Nanocarriers for Monomeric Amphotericin B Delivery.” The invention describes telodendrimer nanocarriers designed to encapsulate amphotericin B while reducing its aggregation. The patent disclosure links reduced aggregation with improved antifungal activity and lower hemolytic effects and cytotoxicity to mammalian cells. In mouse infection models, the optimized nanocarrier reportedly improved antifungal effects and reduced toxicity compared with Fungizone and AmBisome.

Career Highlights

Ji’s listed patent highlights research into nanocarrier design for drug delivery. The disclosed approach focuses on engineering the carrier’s core structure to support monomeric amphotericin B encapsulation and improve its therapeutic profile.

Collaborations

The patent information provided identifies The State University of New York as Ji’s affiliated organization. No additional collaborators are specified in the supplied data.

Conclusion

Xiaotian Ji’s patent work explores telodendrimer nanocarriers as a potential way to improve amphotericin B delivery, balancing antifungal activity with reduced toxicity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…